Daytrana Patch Lawsuit | Daytrana Patch Side-Effects Lawsuit

Daytrana Patch Lawsuit | Daytrana Patch Side-Effects Lawsuit | Side Effects: vitiligo, leukoderma, leucoderma, skin pigmentation

Daytrana Vitiligo Lawsuit, Daytrana Skin Pigmentation Lawsuit, Daytrana Skin Bleaching Lawsuit, Daytrana Skin Color Loss Lawsuit, Daytrana Skin Pigment Loss Lawsuit, Daytrana Patch Lawsuit | Daytrana Patch Side-Effects Lawsuit | Side Effects: vitiligo, leukoderma, leucoderma, skin pigmentation

daytrana-patch-lawsuit-daytrana-patch-side-effects-lawsuitDaytrana, a prescription patch used to treat Attention Deficit Hyperactivity Disorder (ADHD) symptoms in children and adolescents, may cause vitiligo or leukoderma (leucoderma), which is loss of skin pigmentation. The U.S. Food and Drug Administration (FDA) added a new warning to Daytrana patch’s label to include the side effect, which is known as “chemical leukoderma.” The loss of skin color is usually in the areas where the Daytrana patch is worn. The patch is placed in the hip area and transmits a central nervous stimulant through the skin and into the bloodstream. The areas of skin color loss described with the ADHD patch ranged up to 8 inches in diameter. According to the FDA, chemical leukoderma is not physically harmful but may be disfiguring and because it is believed to be irreversible, it may cause emotional distress. The FDA advises patients not to stop using the Daytrana patch without first consulting with their doctors

[, June 24, 2015]

Daytrana Patch Lawsuit Side Effects: vitiligo, leukoderma, leucoderma, skin pigmentation

The Daytrana patch attorneys at Alonso Krangle LLP understand how emotionally devastating a skin condition can be to your child. If your child has sustained permanent skin color loss that may be linked to the Daytrana patch, you and our child may be eligible to obtain monetary damages for pain and suffering and for future medical needs. Alonso Krangle LLP is currently offering free Daytrana vitiligo lawsuit consultations to those who believe that they may have sustained injuries from the ADHD patch. To learn more about filing a Daytrana skin bleaching lawsuit, please contact Alonso Krangle LLP today.

FDA Daytrana Patch Side-Effects Warning

The Daytrana Patch (methylphenidate transdermal system), manufactured by Noven Therapeutics, LLC, has been touted as the first non-oral medication to treat ADHD symptoms. The medication was approved by the FDA in 2006 to treat ADHD symptoms in children 6 to 17 years old. The patch aims to increase a child’s attention and decrease the child’s impulsive and hyperactive behavior. The Daytrana medication, which comes in four dosage strengths, is suppose to be beneficial for children because they do not have to swallow pills. It also may have longer effects on the child than oral medication since the directions call for the patch to be worn for up to 9 hours a day. The patch is to be placed in a different spot each day and on the opposite hip, if possible.

The FDA received 51 adverse events reports from April 2006 to December 2014 and one case that was not recorded in the agency’s database. The FDA stated that time to onset of leukoderma after starting Daytrana ranged from 2 months to 4 years. All of the patients using the patch described a decrease in or loss of skin color, according to the FDA. In most cases, the skin color loss was limited to the areas around where the patch was rotated. However, a small number of patients also reported skin color changes on parts of the body where the patch was never applied. In all cases, the decreased skin color was permanent, according to the FDA.


[, June 24, 2015]

The authors of an article published in June 2012 in the Journal of the American Academy of Dermatology recommended close observation of patients using Daytrana patch to prevent chemical leukoderma. In their article, doctors from the University of California Irvine, Department of Dermatology documented their examination of a 16-year-old patient who had a three-year history of white patches on his hip shortly after he began using the Daytrana patch to treat his ADHD. According to the authors, their patient’s vitiligo was localized in the areas where the patch was applied and did not spread anywhere else, which “suggests that the depigmentation was most likely directly related to patch application.” The doctors were not sure whether the patch’s polyester/ethylene vinyl acetate laminate film, the acrylic or silicone adhesive, or the methylphenidate itself caused the chemical leukoderma.

[, June 2012]

Daytrana Patch Side Effects Lawsuit

According to the Daytrana patch lawyers at Alonso Krangle LLP, court records show that Daytrana skin color loss lawsuits have been filed on behalf of children who have been disfigured allegedly due to the Daytrana transdermal system. If your child has experienced skin pigmentation that could be linked to the Daytrana patch, filing a Daytrana skin pigmentation lawsuit could enable you to obtain monetary damages for your child’s injuries. Alonso Krangle LLP is currently offering free Daytrana skin pigment loss lawsuit consultations. To learn more about the legal options available to you, contact Alonso Krangle LLP by filling out our online form or calling 800-403-6191.

About Alonso Krangle LLP And Filing A Daytrana patch side-effects lawsuit

Andres Alonso and David Krangle, attorneys with 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A nationwide law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey. To discuss filing a Daytrana patch side-effects lawsuit, please contact Alonso Krangle LLP at 1-800-403-6191 or visit our website,

For more information about Alonso Krangle LLP or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website,